Overview

A Study of the Tolerability of Titrated Dose Tramadol/Acetaminophen Combination Tablet in Korean Patients With Osteoarthritis

Status:
Completed

Trial end date:
2006-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the number of osteoarthritis patients receiving titrated or increasing doses of tramadol hydrochloride/acetaminophen combination tablet (titration group) who discontinue treatment due to adverse events to the number of patients receiving a non-titrated dose of tramadol/hydrochloride/acetaminophen combination tablet who discontinue treatment due to adverse events.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen Korea, Ltd., Korea

Treatments:

Acetaminophen
Tramadol